

Slim Weight Loss Clinic operates in New Orleans, Louisiana, providing medically supervised weight management programs centered on GLP-1 receptor agonist therapies. The clinic specializes in obesity treatment through pharmaceutical interventions, offering three FDA-approved medications: semaglutide, tirzepatide, and liraglutide. Each patient undergoes in-person evaluation to determine which GLP-1 therapy aligns with their metabolic profile, weight loss goals, and medical history. The clinic's approach combines prescription medication management with structured nutritional guidance and regular monitoring appointments to track progress and adjust treatment protocols as needed.
The medication protocols at Slim Weight Loss Clinic address the physiological mechanisms of appetite regulation and glucose metabolism. Semaglutide, administered as a once-weekly subcutaneous injection, mimics the incretin hormone GLP-1 to reduce hunger signals and slow gastric emptying. Tirzepatide functions as a dual GIP/GLP-1 receptor agonist, targeting two incretin pathways simultaneously for patients who may benefit from enhanced metabolic effects. Liraglutide, available as a daily injection option, provides an alternative for individuals who prefer more frequent dosing or have specific insurance coverage considerations. The clinic's medical team titrates dosages according to individual tolerance and response, following established clinical protocols for each medication.
Patients at the New Orleans location receive care through scheduled in-person consultations, which include baseline metabolic assessments, body composition analysis, and cardiovascular screening before initiating GLP-1 therapy. The clinic requires regular follow-up visits to monitor weight trends, assess side effects, and provide education on injection technique and medication storage. Medical providers review laboratory work including lipid panels, hemoglobin A1C, and liver function tests to evaluate metabolic improvements beyond weight reduction. The treatment model emphasizes adherence support, as GLP-1 medications require consistent administration schedules and lifestyle modifications to achieve optimal outcomes.
Slim Weight Loss Clinic serves patients throughout the New Orleans metropolitan area who meet clinical criteria for medical weight management, typically defined as a body mass index above 30 or above 27 with weight-related comorbidities such as hypertension, type 2 diabetes, or dyslipidemia. The clinic does not provide surgical weight loss interventions but focuses exclusively on pharmacological approaches combined with behavioral modification strategies. Patients receive individualized meal planning resources and activity recommendations tailored to their current fitness level and medical limitations. The clinic maintains relationships with local laboratories for convenient blood work and coordinates with patients' primary care physicians to ensure integrated care.
The New Orleans clinic operates on an appointment-based schedule with no telehealth options, requiring all consultations and medication dispensing to occur at the physical location. This in-person model allows for direct observation of injection technique, immediate assessment of injection site reactions, and hands-on patient education. The clinic provides refrigeration guidelines for medication storage in Louisiana's humid climate and offers contingency planning for hurricane season preparedness. Patients typically remain under active care for a minimum of six months, with many continuing maintenance therapy long-term depending on weight loss achievement and metabolic health improvements. The clinic accepts various insurance plans for consultation visits, though medication coverage varies significantly by provider and requires prior authorization in most cases.

Dr. Gary T. Marshall, MD, FACS
Surgeon
Practices in New York City.
Dr. Gary Kawesch, MD, FACS
Surgeon
Practices in Los Angeles.
Dr. Thierry Jacquemin, Board Certified
Physician
International board-certified physician.
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


